Published on: October 30, 2024
150 Patients Benefited from Free Multispecialty Health Check-up Camp
A free Ayushman health camp was organized at CHC Laksar under the joint collaboration of Himalayan Hospital Jolly Grant, National Health Mission Uttarakhand, and the Chief Medical Officer’s office, Haridwar. More than 150 patients benefited from free health check-ups at their doorstep.
A free Ayushman health check-up camp was organized by the Community Medicine Department of Himalayan Institute of Medical Sciences (HIMS) Jolly Grant at the Community Health Center Laksar (Haridwar). Under the guidance of HIMS Principal Dr. AK Deorari, the camp included various medical specialists: camp coordinator Dr. Surabhi Mishra Community Medicine, Dr. Shubhranshu Jugran from General Medicine, Dr. Surabhi Chaudhary from Pediatrics, Dr. Simran Soni from Ophthalmology, Dr. Divyanee Gulati from Gynecology, Dr. Sanjeeva Kumar from Dental Surgery, Dr. Sukant Tomar from Orthopedics, and Dr. Anshu Prasad from Psychiatry. These doctors examined around 150 patients and provided appropriate consultations.
Head of the Community Medicine Department and Nodal Officer Dr. Ashok Kumar Srivastava informed that patients attending the free health check-up camp received registration, consultations, and free tests for sugar, BP, hemoglobin, among others, as well as free medicine distribution.
Dr. Niharika Verma informed that discussions were held with the public on topics such as maternal health, child nutrition, and mental health. MBBS trainees Muskan Jain, Narinder Garg. Mohd. Sameer assisted in the operation of the health camp.
Prof Rakesh Kumar
Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.
Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.
With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.
A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.
Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.